Veröffentlichungen
Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer
Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.
- [o.368] Disease activity and stress are linked in a subpopulation of chronic spontaneous urticaria patients (6)
- [o.172] Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria (0)
- [o.627] Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients (0)
- [o.510] Disease impact, diagnostic delay, and unmet medical needs of patients with cholinergic urticaria in German-speaking countries (0)
- [o.606] Disease modification in chronic spontaneous urticaria (3)
- [o.621] Disparities in geography and race in hereditary angioedema: analysis of 64 trials & 4354 patients (0)
- [o.612] Distinct clinical profiles of IgE and IgG autoantibodies to thyroid peroxidase in chronic spontaneous urticaria (0)
- [o.601] Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab? (0)
- [o.500] Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome (0)
- [o.598] Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials (0)
- [o.357] Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review (0)
- [o.620] Dupilumab reduces urticaria activity, itch, and hives in patients with chronic spontaneous urticaria regardless of baseline serum immunoglobulin E levels (0)
- [o.422] EAACI biological guidelines – dupilumab for children and adults with moderate-to-severe atopic dermatitis (0)
- [o.467] EAACI biological guidelines – omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old (0)
- [o.144] EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria (0)
- [o.084] EAACI/GA²LEN task force consensus report: the autologous serum skin test in urticaria (2)
- [o.048] EAACI/GA²LEN/EDF guideline: definition, classification and diagnosis of urticaria (1)
- [o.047] EAACI/GA²LEN/EDF guideline: management of urticaria (0)
- [o.080] EAACI/GA²LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria (1)
- [o.079] EAACI/GA²LEN/EDF/WAO guideline: management of urticaria (0)
(Last update: 06.2026)
| Number of original publications in peer-reviewed journals: | 662 |
| Number of reviews in peer-reviewed journals: | 231 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 893 |
| Cumulative IF for original publications in peer-reviewed journals: | 4768.99 |
| Cumulative IF for reviews in peer-reviewed journals: | 1703.12 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 6472.11 |
| Total number of citations: 45.522, h-index: 109 (Web of Science Juli 2025) | 45522 |
Download-Information
Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.